Alessandro Dei



Alessandro is a Scientist at STEMCELL Technologies (Cambridge, UK). He obtained a Bachelor’s Degree in Biological and Molecular Sciences at the University of Pisa, and continued here his studies with a Master in Biomedicine. During his Master, he worked for a year as an intern in the Department of Virology at the University Hospital of Cisanello (AOUP, Pisa, Italy) where he gained expertise on clinical diagnostic virology. His Master’s thesis project evaluated the utility of microarray technology in the diagnosis of viral respiratory tract infections. Prior to his graduation, Alessandro was awarded an Erasmus Placement Scholarship that allowed him to work in Mersin University Hospital (Turkey) for 9 months to broaden his skills in microbiology. In 2017, he was awarded a MSCA scholarship to pursue a Ph.D. in Bioengineering at the University of Galway (Ireland). He became one of the Early Stage Researchers of the Tendon Therapy Train Consortium, based at STEMCELL Technologies (Cambridge, UK), where he successfully developed cell culture media and protocols to differentiate human mesenchymal stem cells and pluripotent stem cells to cells with tenocyte-like properties.

Within GUTVIBRATIONS, Alessandro will be supervised by Dr. Salvatore Simmini (Senior Scientist at STEMCELL Technologies).

Allessandro’s research project

Alessandro is working in the Research and Development Department at STEMCELL Technologies (Cambridge, UK). His project aims to develop and optimize robust cell culture media and protocols for specific in vitro co-culture systems involving human intestinal epithelial, immune, endothelial and neural cells.


About STEMCELL Technologies

STEMCELL Technologies Inc. is a privately-owned biotechnology company based in Vancouver that helps power leading-edge life science research around the world. Scientists performing stem cell, immunology, cancer, regenerative medicine and cellular therapy research are among those who rely on our cell culture media, cell separation products, instruments, ancillary reagents and contract assay services. We create novel, useful, standardized products of unfailing quality and deliver them to more than 70 countries via our many regional offices plus distribution centres in Vancouver, Seattle, Grenoble and Singapore.  Driven by our love of science and our passion for quality, we see ourselves simply as “Scientists Helping Scientists” – standing by our customers to provide outstanding products, technical support and training.  We have over 1000 science-oriented employees globally, including 250 PhDs/MScs, with most others holding a BSc or engineering degree.  STEMCELL is proud to be the largest Biotechnology employer in Canada.


STEMCELL is continuing to expand its European operations, particularly in the areas of R&D personnel and facilities, manufacturing, quality control, quality assurance and regulatory activities that will meet the highest levels of European research and regular standards. STEMCELL UK Ltd. (STUK) was established in July 2014. In 2016 STUK expanded its capabilities to include research and development (R&D) with staff located in laboratory space in Cambridge, UK, including fully functional laboratory space containing state of the art cell culture and analytical chemistry equipment as well as an ISO 13485-certified manufacturing clean room that is adopting single use technology and closed systems for manufacturing higher compliance media and culture reagents.